trivorin 200 mg capsulas
laboratorios elmor, s.a. - ribavirina - capsulas - 200 mg
revolade
novartis europharm limited - eltrombopag - púrpura, trombocitopénica, idiopática - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 y 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 y 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
pegasys 180 mcg solución inyectable
imed orphan s.a. (distribución exclusiva del producto por laboratorio libra s.a.) - solución inyectable - peginterferón alfa-2a 180 mcg inyectable
irbesartan 300mg tableta
vita pharma s.a.c. - tableta - por jeringa prellenada1 ml; irbesartan 300.000000 mg; - peginterferón alfa-2a
plegridy 63 94 mcg 2 xeringues precarregades 0.5 ml
plegridy 63 94 mcg 2 plumes precarregades 0.5 ml
plegridy 125 mcg 2 xeringues precarregades 0.5 ml
plegridy 125 mcg 2 plumes precarregades 0.5 ml
sofosbuvir
natco pharma limited. - sofosbuvir - tableta revestida - 400 mg
sofovir 400mg tableta recubierta
seven pharma s.a.c. - droguerÍa - tableta recubierta - por tableta - - sofosbuvir